Oppenheimer & Co. Inc. Lowers Stock Position in iShares Biotechnology ETF $IBB

Oppenheimer & Co. Inc. lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 12.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,980 shares of the financial services provider’s stock after selling 3,287 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $3,878,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its holdings in iShares Biotechnology ETF by 46,806.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after purchasing an additional 46,806 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $1,907,000. Central Pacific Bank Trust Division boosted its holdings in iShares Biotechnology ETF by 296,500.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after purchasing an additional 14,825 shares in the last quarter. Florin Court Capital LLP purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $11,116,000. Finally, SG Americas Securities LLC boosted its holdings in iShares Biotechnology ETF by 96.3% in the 3rd quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock valued at $4,125,000 after purchasing an additional 14,016 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $167.27 on Monday. iShares Biotechnology ETF has a twelve month low of $116.25 and a twelve month high of $179.64. The stock’s 50 day moving average is $169.84 and its two-hundred day moving average is $168.65.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.